ArticleExperimental and therapeutic medicine2026
Intralobar pulmonary sequestration coexisting with pulmonary cryptococcosis: A case report and literature review.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary sequestration (PS) is a rare congenital foregut abnormality characterized by non-functioning lung tissue that receives an arterial blood supply from an anomalous systemic artery, typically the aorta, and is separated from the normal tracheobronchial tree. It often presents as a mass-like, cystic, cavitary or pneumonic lesion on imaging. Patients often present with symptoms of recurrent pulmonary infection; however, cryptococcal infection is rare. The present case study reports on a 52-year-old man with PS and cryptococcal infection. The mass in the lower lobe of the right lung was removed by video-assisted thoracoscopic surgery and diagnosed as PS. Furthermore, the nodule present in the left inferior lobe was identified as cryptococcal infection by percutaneous lung biopsy. Pulmonary cryptococcosis (PC) disappeared after antifungal treatment. During the 3-year follow-up, the patient was in good condition and no recurrence of either disease was observed on contrast-enhanced CT. The present unique case of intralobar PS with a contralateral PC nodule underscores that in the absence of a classic systemic feeding artery on imaging, percutaneous biopsy is a key step in diagnosing PS and excluding malignancy. This demonstrates the necessity for anatomy-driven management strategies, whereby spatially separated pathologies warrant a combined approach of surgical resection for the PS and targeted antifungal therapy for the PC. The definitive exclusion of cryptococcal infection within the resected PS tissue argues for a coincidental coexistence in this immunocompetent host, highlighting the importance of evaluating each lesion independently rather than seeking a unifying diagnosis in complex pulmonary presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.